targetId,subgroupId,cohortId,cohortType,name
1001,1,1001000011,TwS,Hydroxychloroquine  with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1002,1,1002000011,TwS,Hydroxychloroquine + Azithromycin  with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1003,1,1003000011,TwS,Hydroxychloroquine + Fluoroquinolones with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1004,1,1004000011,TwS,Hydroxychloroquine + Amoxicillin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1005,1,1005000011,TwS,Hydroxychloroquine + ceftriaxone with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1006,1,1006000011,TwS,Chloroquine with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1007,1,1007000011,TwS,Azithromycin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1008,1,1008000011,TwS,Fluoroquinolones with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1009,1,1009000011,TwS,Amoxicillin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1010,1,1010000011,TwS,Ceftriaxone with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1011,1,1011000011,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation"
1012,1,1012000011,TwS,tocilizumab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1013,1,1013000011,TwS,siltuximab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1014,1,1014000011,TwS,sarilumab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1015,1,1015000011,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation"
1016,1,1016000011,TwS,baricitinib with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1017,1,1017000011,TwS,tofacitinib with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1018,1,1018000011,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation"
1019,1,1019000011,TwS,adalimumab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1020,1,1020000011,TwS,etanercept with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1021,1,1021000011,TwS,infliximab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1022,1,1022000011,TwS,ustekinumab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1023,1,1023000011,TwS,Anakinra with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1024,1,1024000011,TwS,HIV Protease inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1025,1,1025000011,TwS,ritonavir/lopinavir with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1026,1,1026000011,TwS,Interferon beta 1b with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1027,1,1027000011,TwS,Interferon beta 1a with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1028,1,1028000011,TwS,Interferon alfa 2a with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1029,1,1029000011,TwS,favipiravir with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1030,1,1030000011,TwS,Remdesivir with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1031,1,1031000011,TwS,ribavirin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1032,1,1032000011,TwS,oseltamivir with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1033,1,1033000011,TwS,Ivermectin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1034,1,1034000011,TwS,itraconazole with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1035,1,1035000011,TwS,warfarin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1036,1,1036000011,TwS,heparin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1037,1,1037000011,TwS,enoxaparin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1038,1,1038000011,TwS,edoxaban with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1039,1,1039000011,TwS,dabigatran with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1040,1,1040000011,TwS,rivaroxaban with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1041,1,1041000011,TwS,acenocoumarol with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1042,1,1042000011,TwS,apixaban with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1043,1,1043000011,TwS,bemiparin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1044,1,1044000011,TwS,clopidogrel with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1045,1,1045000011,TwS,aspirin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1046,1,1046000011,TwS,prasugrel with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1047,1,1047000011,TwS,alteplase with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1048,1,1048000011,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation"
1049,1,1049000011,TwS,tranexamic acid with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1050,1,1050000011,TwS,Ruxolitinib with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1052,1,1052000011,TwS,ACE inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1053,1,1053000011,TwS,Angiotensin receptor blockers (ARBs) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1054,1,1054000011,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1055,1,1055000011,TwS,Thiazide or thiazide-like diuretics with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1056,1,1056000011,TwS,Hydrocortisone with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1057,1,1057000011,TwS,dexamethasone with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1058,1,1058000011,TwS,prednisone or prednisolone with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1059,1,1059000011,TwS,raloxifene with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1060,1,1060000011,TwS,Bevacizumab with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1061,1,1061000011,TwS,Fingolimod with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1062,1,1062000011,TwS,eculizumab  with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1063,1,1063000011,TwS,Statins with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1064,1,1064000011,TwS,metformin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1065,1,1065000011,TwS,DPP-4 inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1066,1,1066000011,TwS,SGLT2 inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1067,1,1067000011,TwS,GLP1 inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1068,1,1068000011,TwS,H2 receptor antagonist with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1069,1,1069000011,TwS,famotidine with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1070,1,1070000011,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation"
1071,1,1071000011,TwS,prazosin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1072,1,1072000011,TwS,terazosin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1073,1,1073000011,TwS,doxazosin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1074,1,1074000011,TwS,tamsulosin with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1075,1,1075000011,TwS,BCG vaccine with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1076,1,1076000011,TwS,Colchicine with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1077,1,1077000011,TwS,Losartan with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1078,1,1078000011,TwS,cholecalciferol with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1079,1,1079000011,TwS,Ibrutinib with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1080,1,1080000011,TwS,abiraterone with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1081,1,1081000011,TwS,bicalutamide with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1082,1,1082000011,TwS,emtricitabine with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1083,1,1083000011,TwS,tacrolimus with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1100,1,1100000011,TwS,antivirals in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1101,1,1101000011,TwS,immune-based therapies in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1102,1,1102000011,TwS,antithrombotics in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1103,1,1103000011,TwS,antibiotics in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1104,1,1104000011,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1105,1,1105000011,TwS,antidiabetics in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1106,1,1106000011,TwS,concomitant therapies in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services and 365d prior observation
1001,2,1001000021,TwS,Hydroxychloroquine  with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1002,2,1002000021,TwS,Hydroxychloroquine + Azithromycin  with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1003,2,1003000021,TwS,Hydroxychloroquine + Fluoroquinolones with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1004,2,1004000021,TwS,Hydroxychloroquine + Amoxicillin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1005,2,1005000021,TwS,Hydroxychloroquine + ceftriaxone with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1006,2,1006000021,TwS,Chloroquine with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1007,2,1007000021,TwS,Azithromycin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1008,2,1008000021,TwS,Fluoroquinolones with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1009,2,1009000021,TwS,Amoxicillin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1010,2,1010000021,TwS,Ceftriaxone with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1011,2,1011000021,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation"
1012,2,1012000021,TwS,tocilizumab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1013,2,1013000021,TwS,siltuximab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1014,2,1014000021,TwS,sarilumab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1015,2,1015000021,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation"
1016,2,1016000021,TwS,baricitinib with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1017,2,1017000021,TwS,tofacitinib with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1018,2,1018000021,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation"
1019,2,1019000021,TwS,adalimumab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1020,2,1020000021,TwS,etanercept with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1021,2,1021000021,TwS,infliximab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1022,2,1022000021,TwS,ustekinumab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1023,2,1023000021,TwS,Anakinra with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1024,2,1024000021,TwS,HIV Protease inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1025,2,1025000021,TwS,ritonavir/lopinavir with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1026,2,1026000021,TwS,Interferon beta 1b with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1027,2,1027000021,TwS,Interferon beta 1a with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1028,2,1028000021,TwS,Interferon alfa 2a with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1029,2,1029000021,TwS,favipiravir with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1030,2,1030000021,TwS,Remdesivir with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1031,2,1031000021,TwS,ribavirin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1032,2,1032000021,TwS,oseltamivir with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1033,2,1033000021,TwS,Ivermectin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1034,2,1034000021,TwS,itraconazole with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1035,2,1035000021,TwS,warfarin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1036,2,1036000021,TwS,heparin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1037,2,1037000021,TwS,enoxaparin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1038,2,1038000021,TwS,edoxaban with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1039,2,1039000021,TwS,dabigatran with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1040,2,1040000021,TwS,rivaroxaban with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1041,2,1041000021,TwS,acenocoumarol with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1042,2,1042000021,TwS,apixaban with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1043,2,1043000021,TwS,bemiparin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1044,2,1044000021,TwS,clopidogrel with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1045,2,1045000021,TwS,aspirin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1046,2,1046000021,TwS,prasugrel with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1047,2,1047000021,TwS,alteplase with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1048,2,1048000021,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation"
1049,2,1049000021,TwS,tranexamic acid with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1050,2,1050000021,TwS,Ruxolitinib with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1052,2,1052000021,TwS,ACE inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1053,2,1053000021,TwS,Angiotensin receptor blockers (ARBs) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1054,2,1054000021,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1055,2,1055000021,TwS,Thiazide or thiazide-like diuretics with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1056,2,1056000021,TwS,Hydrocortisone with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1057,2,1057000021,TwS,dexamethasone with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1058,2,1058000021,TwS,prednisone or prednisolone with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1059,2,1059000021,TwS,raloxifene with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1060,2,1060000021,TwS,Bevacizumab with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1061,2,1061000021,TwS,Fingolimod with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1062,2,1062000021,TwS,eculizumab  with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1063,2,1063000021,TwS,Statins with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1064,2,1064000021,TwS,metformin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1065,2,1065000021,TwS,DPP-4 inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1066,2,1066000021,TwS,SGLT2 inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1067,2,1067000021,TwS,GLP1 inhibitors with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1068,2,1068000021,TwS,H2 receptor antagonist with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1069,2,1069000021,TwS,famotidine with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1070,2,1070000021,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation"
1071,2,1071000021,TwS,prazosin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1072,2,1072000021,TwS,terazosin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1073,2,1073000021,TwS,doxazosin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1074,2,1074000021,TwS,tamsulosin with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1075,2,1075000021,TwS,BCG vaccine with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1076,2,1076000021,TwS,Colchicine with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1077,2,1077000021,TwS,Losartan with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1078,2,1078000021,TwS,cholecalciferol with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1079,2,1079000021,TwS,Ibrutinib with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1080,2,1080000021,TwS,abiraterone with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1081,2,1081000021,TwS,bicalutamide with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1082,2,1082000021,TwS,emtricitabine with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1083,2,1083000021,TwS,tacrolimus with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1100,2,1100000021,TwS,antivirals in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1101,2,1101000021,TwS,immune-based therapies in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1102,2,1102000021,TwS,antithrombotics in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1103,2,1103000021,TwS,antibiotics in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1104,2,1104000021,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1105,2,1105000021,TwS,antidiabetics in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1106,2,1106000021,TwS,concomitant therapies in SCYLLA with Treatment administered on the date of admission of hospitalization and prior to intensive services with no prior observation
1001,3,1001000031,TwS,Hydroxychloroquine  with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1002,3,1002000031,TwS,Hydroxychloroquine + Azithromycin  with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1003,3,1003000031,TwS,Hydroxychloroquine + Fluoroquinolones with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1004,3,1004000031,TwS,Hydroxychloroquine + Amoxicillin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1005,3,1005000031,TwS,Hydroxychloroquine + ceftriaxone with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1006,3,1006000031,TwS,Chloroquine with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1007,3,1007000031,TwS,Azithromycin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1008,3,1008000031,TwS,Fluoroquinolones with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1009,3,1009000031,TwS,Amoxicillin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1010,3,1010000031,TwS,Ceftriaxone with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1011,3,1011000031,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation"
1012,3,1012000031,TwS,tocilizumab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1013,3,1013000031,TwS,siltuximab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1014,3,1014000031,TwS,sarilumab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1015,3,1015000031,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation"
1016,3,1016000031,TwS,baricitinib with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1017,3,1017000031,TwS,tofacitinib with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1018,3,1018000031,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation"
1019,3,1019000031,TwS,adalimumab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1020,3,1020000031,TwS,etanercept with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1021,3,1021000031,TwS,infliximab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1022,3,1022000031,TwS,ustekinumab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1023,3,1023000031,TwS,Anakinra with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1024,3,1024000031,TwS,HIV Protease inhibitors with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1025,3,1025000031,TwS,ritonavir/lopinavir with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1026,3,1026000031,TwS,Interferon beta 1b with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1027,3,1027000031,TwS,Interferon beta 1a with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1028,3,1028000031,TwS,Interferon alfa 2a with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1029,3,1029000031,TwS,favipiravir with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1030,3,1030000031,TwS,Remdesivir with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1031,3,1031000031,TwS,ribavirin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1032,3,1032000031,TwS,oseltamivir with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1033,3,1033000031,TwS,Ivermectin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1034,3,1034000031,TwS,itraconazole with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1035,3,1035000031,TwS,warfarin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1036,3,1036000031,TwS,heparin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1037,3,1037000031,TwS,enoxaparin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1038,3,1038000031,TwS,edoxaban with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1039,3,1039000031,TwS,dabigatran with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1040,3,1040000031,TwS,rivaroxaban with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1041,3,1041000031,TwS,acenocoumarol with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1042,3,1042000031,TwS,apixaban with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1043,3,1043000031,TwS,bemiparin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1044,3,1044000031,TwS,clopidogrel with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1045,3,1045000031,TwS,aspirin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1046,3,1046000031,TwS,prasugrel with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1047,3,1047000031,TwS,alteplase with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1048,3,1048000031,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation"
1049,3,1049000031,TwS,tranexamic acid with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1050,3,1050000031,TwS,Ruxolitinib with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1052,3,1052000031,TwS,ACE inhibitors with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1053,3,1053000031,TwS,Angiotensin receptor blockers (ARBs) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1054,3,1054000031,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1055,3,1055000031,TwS,Thiazide or thiazide-like diuretics with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1056,3,1056000031,TwS,Hydrocortisone with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1057,3,1057000031,TwS,dexamethasone with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1058,3,1058000031,TwS,prednisone or prednisolone with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1059,3,1059000031,TwS,raloxifene with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1060,3,1060000031,TwS,Bevacizumab with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1061,3,1061000031,TwS,Fingolimod with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1062,3,1062000031,TwS,eculizumab  with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1063,3,1063000031,TwS,Statins with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1064,3,1064000031,TwS,metformin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1065,3,1065000031,TwS,DPP-4 inhibitors with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1066,3,1066000031,TwS,SGLT2 inhibitors with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1067,3,1067000031,TwS,GLP1 inhibitors with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1068,3,1068000031,TwS,H2 receptor antagonist with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1069,3,1069000031,TwS,famotidine with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1070,3,1070000031,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Treatment administered during hospitalization and prior to intensive services and 365d prior observation"
1071,3,1071000031,TwS,prazosin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1072,3,1072000031,TwS,terazosin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1073,3,1073000031,TwS,doxazosin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1074,3,1074000031,TwS,tamsulosin with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1075,3,1075000031,TwS,BCG vaccine with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1076,3,1076000031,TwS,Colchicine with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1077,3,1077000031,TwS,Losartan with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1078,3,1078000031,TwS,cholecalciferol with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1079,3,1079000031,TwS,Ibrutinib with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1080,3,1080000031,TwS,abiraterone with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1081,3,1081000031,TwS,bicalutamide with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1082,3,1082000031,TwS,emtricitabine with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1083,3,1083000031,TwS,tacrolimus with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1100,3,1100000031,TwS,antivirals in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1101,3,1101000031,TwS,immune-based therapies in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1102,3,1102000031,TwS,antithrombotics in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1103,3,1103000031,TwS,antibiotics in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1104,3,1104000031,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1105,3,1105000031,TwS,antidiabetics in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1106,3,1106000031,TwS,concomitant therapies in SCYLLA with Treatment administered during hospitalization and prior to intensive services and 365d prior observation
1001,2001,1001020011,TwS,Hydroxychloroquine  with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1002,2001,1002020011,TwS,Hydroxychloroquine + Azithromycin  with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1003,2001,1003020011,TwS,Hydroxychloroquine + Fluoroquinolones with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1004,2001,1004020011,TwS,Hydroxychloroquine + Amoxicillin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1005,2001,1005020011,TwS,Hydroxychloroquine + ceftriaxone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1006,2001,1006020011,TwS,Chloroquine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1007,2001,1007020011,TwS,Azithromycin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1008,2001,1008020011,TwS,Fluoroquinolones with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1009,2001,1009020011,TwS,Amoxicillin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1010,2001,1010020011,TwS,Ceftriaxone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1011,2001,1011020011,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1012,2001,1012020011,TwS,tocilizumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1013,2001,1013020011,TwS,siltuximab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1014,2001,1014020011,TwS,sarilumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1015,2001,1015020011,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1016,2001,1016020011,TwS,baricitinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1017,2001,1017020011,TwS,tofacitinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1018,2001,1018020011,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1019,2001,1019020011,TwS,adalimumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1020,2001,1020020011,TwS,etanercept with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1021,2001,1021020011,TwS,infliximab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1022,2001,1022020011,TwS,ustekinumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1023,2001,1023020011,TwS,Anakinra with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1024,2001,1024020011,TwS,HIV Protease inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1025,2001,1025020011,TwS,ritonavir/lopinavir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1026,2001,1026020011,TwS,Interferon beta 1b with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1027,2001,1027020011,TwS,Interferon beta 1a with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1028,2001,1028020011,TwS,Interferon alfa 2a with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1029,2001,1029020011,TwS,favipiravir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1030,2001,1030020011,TwS,Remdesivir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1031,2001,1031020011,TwS,ribavirin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1032,2001,1032020011,TwS,oseltamivir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1033,2001,1033020011,TwS,Ivermectin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1034,2001,1034020011,TwS,itraconazole with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1035,2001,1035020011,TwS,warfarin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1036,2001,1036020011,TwS,heparin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1037,2001,1037020011,TwS,enoxaparin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1038,2001,1038020011,TwS,edoxaban with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1039,2001,1039020011,TwS,dabigatran with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1040,2001,1040020011,TwS,rivaroxaban with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1041,2001,1041020011,TwS,acenocoumarol with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1042,2001,1042020011,TwS,apixaban with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1043,2001,1043020011,TwS,bemiparin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1044,2001,1044020011,TwS,clopidogrel with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1045,2001,1045020011,TwS,aspirin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1046,2001,1046020011,TwS,prasugrel with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1047,2001,1047020011,TwS,alteplase with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1048,2001,1048020011,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1049,2001,1049020011,TwS,tranexamic acid with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1050,2001,1050020011,TwS,Ruxolitinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1052,2001,1052020011,TwS,ACE inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1053,2001,1053020011,TwS,Angiotensin receptor blockers (ARBs) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1054,2001,1054020011,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1055,2001,1055020011,TwS,Thiazide or thiazide-like diuretics with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1056,2001,1056020011,TwS,Hydrocortisone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1057,2001,1057020011,TwS,dexamethasone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1058,2001,1058020011,TwS,prednisone or prednisolone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1059,2001,1059020011,TwS,raloxifene with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1060,2001,1060020011,TwS,Bevacizumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1061,2001,1061020011,TwS,Fingolimod with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1062,2001,1062020011,TwS,eculizumab  with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1063,2001,1063020011,TwS,Statins with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1064,2001,1064020011,TwS,metformin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1065,2001,1065020011,TwS,DPP-4 inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1066,2001,1066020011,TwS,SGLT2 inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1067,2001,1067020011,TwS,GLP1 inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1068,2001,1068020011,TwS,H2 receptor antagonist with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1069,2001,1069020011,TwS,famotidine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1070,2001,1070020011,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1071,2001,1071020011,TwS,prazosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1072,2001,1072020011,TwS,terazosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1073,2001,1073020011,TwS,doxazosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1074,2001,1074020011,TwS,tamsulosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1075,2001,1075020011,TwS,BCG vaccine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1076,2001,1076020011,TwS,Colchicine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1077,2001,1077020011,TwS,Losartan with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1078,2001,1078020011,TwS,cholecalciferol with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1079,2001,1079020011,TwS,Ibrutinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1080,2001,1080020011,TwS,abiraterone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1081,2001,1081020011,TwS,bicalutamide with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1082,2001,1082020011,TwS,emtricitabine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1083,2001,1083020011,TwS,tacrolimus with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1100,2001,1100020011,TwS,antivirals in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1101,2001,1101020011,TwS,immune-based therapies in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1102,2001,1102020011,TwS,antithrombotics in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1103,2001,1103020011,TwS,antibiotics in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1104,2001,1104020011,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1105,2001,1105020011,TwS,antidiabetics in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1106,2001,1106020011,TwS,concomitant therapies in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1001,2002,1001020021,TwS,Hydroxychloroquine  with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1002,2002,1002020021,TwS,Hydroxychloroquine + Azithromycin  with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1003,2002,1003020021,TwS,Hydroxychloroquine + Fluoroquinolones with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1004,2002,1004020021,TwS,Hydroxychloroquine + Amoxicillin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1005,2002,1005020021,TwS,Hydroxychloroquine + ceftriaxone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1006,2002,1006020021,TwS,Chloroquine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1007,2002,1007020021,TwS,Azithromycin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1008,2002,1008020021,TwS,Fluoroquinolones with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1009,2002,1009020021,TwS,Amoxicillin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1010,2002,1010020021,TwS,Ceftriaxone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1011,2002,1011020021,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1012,2002,1012020021,TwS,tocilizumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1013,2002,1013020021,TwS,siltuximab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1014,2002,1014020021,TwS,sarilumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1015,2002,1015020021,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1016,2002,1016020021,TwS,baricitinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1017,2002,1017020021,TwS,tofacitinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1018,2002,1018020021,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1019,2002,1019020021,TwS,adalimumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1020,2002,1020020021,TwS,etanercept with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1021,2002,1021020021,TwS,infliximab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1022,2002,1022020021,TwS,ustekinumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1023,2002,1023020021,TwS,Anakinra with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1024,2002,1024020021,TwS,HIV Protease inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1025,2002,1025020021,TwS,ritonavir/lopinavir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1026,2002,1026020021,TwS,Interferon beta 1b with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1027,2002,1027020021,TwS,Interferon beta 1a with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1028,2002,1028020021,TwS,Interferon alfa 2a with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1029,2002,1029020021,TwS,favipiravir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1030,2002,1030020021,TwS,Remdesivir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1031,2002,1031020021,TwS,ribavirin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1032,2002,1032020021,TwS,oseltamivir with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1033,2002,1033020021,TwS,Ivermectin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1034,2002,1034020021,TwS,itraconazole with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1035,2002,1035020021,TwS,warfarin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1036,2002,1036020021,TwS,heparin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1037,2002,1037020021,TwS,enoxaparin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1038,2002,1038020021,TwS,edoxaban with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1039,2002,1039020021,TwS,dabigatran with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1040,2002,1040020021,TwS,rivaroxaban with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1041,2002,1041020021,TwS,acenocoumarol with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1042,2002,1042020021,TwS,apixaban with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1043,2002,1043020021,TwS,bemiparin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1044,2002,1044020021,TwS,clopidogrel with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1045,2002,1045020021,TwS,aspirin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1046,2002,1046020021,TwS,prasugrel with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1047,2002,1047020021,TwS,alteplase with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1048,2002,1048020021,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1049,2002,1049020021,TwS,tranexamic acid with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1050,2002,1050020021,TwS,Ruxolitinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1052,2002,1052020021,TwS,ACE inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1053,2002,1053020021,TwS,Angiotensin receptor blockers (ARBs) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1054,2002,1054020021,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1055,2002,1055020021,TwS,Thiazide or thiazide-like diuretics with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1056,2002,1056020021,TwS,Hydrocortisone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1057,2002,1057020021,TwS,dexamethasone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1058,2002,1058020021,TwS,prednisone or prednisolone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1059,2002,1059020021,TwS,raloxifene with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1060,2002,1060020021,TwS,Bevacizumab with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1061,2002,1061020021,TwS,Fingolimod with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1062,2002,1062020021,TwS,eculizumab  with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1063,2002,1063020021,TwS,Statins with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1064,2002,1064020021,TwS,metformin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1065,2002,1065020021,TwS,DPP-4 inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1066,2002,1066020021,TwS,SGLT2 inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1067,2002,1067020021,TwS,GLP1 inhibitors with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1068,2002,1068020021,TwS,H2 receptor antagonist with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1069,2002,1069020021,TwS,famotidine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1070,2002,1070020021,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1071,2002,1071020021,TwS,prazosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1072,2002,1072020021,TwS,terazosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1073,2002,1073020021,TwS,doxazosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1074,2002,1074020021,TwS,tamsulosin with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1075,2002,1075020021,TwS,BCG vaccine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1076,2002,1076020021,TwS,Colchicine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1077,2002,1077020021,TwS,Losartan with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1078,2002,1078020021,TwS,cholecalciferol with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1079,2002,1079020021,TwS,Ibrutinib with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1080,2002,1080020021,TwS,abiraterone with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1081,2002,1081020021,TwS,bicalutamide with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1082,2002,1082020021,TwS,emtricitabine with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1083,2002,1083020021,TwS,tacrolimus with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1100,2002,1100020021,TwS,antivirals in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1101,2002,1101020021,TwS,immune-based therapies in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1102,2002,1102020021,TwS,antithrombotics in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1103,2002,1103020021,TwS,antibiotics in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1104,2002,1104020021,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1105,2002,1105020021,TwS,antidiabetics in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1106,2002,1106020021,TwS,concomitant therapies in SCYLLA with Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1001,2003,1001020031,TwS,"Hydroxychloroquine  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1002,2003,1002020031,TwS,"Hydroxychloroquine + Azithromycin  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1003,2003,1003020031,TwS,"Hydroxychloroquine + Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1004,2003,1004020031,TwS,"Hydroxychloroquine + Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1005,2003,1005020031,TwS,"Hydroxychloroquine + ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1006,2003,1006020031,TwS,"Chloroquine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1007,2003,1007020031,TwS,"Azithromycin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1008,2003,1008020031,TwS,"Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1009,2003,1009020031,TwS,"Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1010,2003,1010020031,TwS,"Ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1011,2003,1011020031,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1012,2003,1012020031,TwS,"tocilizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1013,2003,1013020031,TwS,"siltuximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1014,2003,1014020031,TwS,"sarilumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1015,2003,1015020031,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1016,2003,1016020031,TwS,"baricitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1017,2003,1017020031,TwS,"tofacitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1018,2003,1018020031,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1019,2003,1019020031,TwS,"adalimumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1020,2003,1020020031,TwS,"etanercept with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1021,2003,1021020031,TwS,"infliximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1022,2003,1022020031,TwS,"ustekinumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1023,2003,1023020031,TwS,"Anakinra with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1024,2003,1024020031,TwS,"HIV Protease inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1025,2003,1025020031,TwS,"ritonavir/lopinavir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1026,2003,1026020031,TwS,"Interferon beta 1b with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1027,2003,1027020031,TwS,"Interferon beta 1a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1028,2003,1028020031,TwS,"Interferon alfa 2a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1029,2003,1029020031,TwS,"favipiravir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1030,2003,1030020031,TwS,"Remdesivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1031,2003,1031020031,TwS,"ribavirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1032,2003,1032020031,TwS,"oseltamivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1033,2003,1033020031,TwS,"Ivermectin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1034,2003,1034020031,TwS,"itraconazole with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1035,2003,1035020031,TwS,"warfarin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1036,2003,1036020031,TwS,"heparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1037,2003,1037020031,TwS,"enoxaparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1038,2003,1038020031,TwS,"edoxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1039,2003,1039020031,TwS,"dabigatran with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1040,2003,1040020031,TwS,"rivaroxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1041,2003,1041020031,TwS,"acenocoumarol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1042,2003,1042020031,TwS,"apixaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1043,2003,1043020031,TwS,"bemiparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1044,2003,1044020031,TwS,"clopidogrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1045,2003,1045020031,TwS,"aspirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1046,2003,1046020031,TwS,"prasugrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1047,2003,1047020031,TwS,"alteplase with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1048,2003,1048020031,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1049,2003,1049020031,TwS,"tranexamic acid with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1050,2003,1050020031,TwS,"Ruxolitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1052,2003,1052020031,TwS,"ACE inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1053,2003,1053020031,TwS,"Angiotensin receptor blockers (ARBs) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1054,2003,1054020031,TwS,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1055,2003,1055020031,TwS,"Thiazide or thiazide-like diuretics with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1056,2003,1056020031,TwS,"Hydrocortisone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1057,2003,1057020031,TwS,"dexamethasone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1058,2003,1058020031,TwS,"prednisone or prednisolone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1059,2003,1059020031,TwS,"raloxifene with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1060,2003,1060020031,TwS,"Bevacizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1061,2003,1061020031,TwS,"Fingolimod with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1062,2003,1062020031,TwS,"eculizumab  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1063,2003,1063020031,TwS,"Statins with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1064,2003,1064020031,TwS,"metformin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1065,2003,1065020031,TwS,"DPP-4 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1066,2003,1066020031,TwS,"SGLT2 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1067,2003,1067020031,TwS,"GLP1 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1068,2003,1068020031,TwS,"H2 receptor antagonist with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1069,2003,1069020031,TwS,"famotidine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1070,2003,1070020031,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1071,2003,1071020031,TwS,"prazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1072,2003,1072020031,TwS,"terazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1073,2003,1073020031,TwS,"doxazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1074,2003,1074020031,TwS,"tamsulosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1075,2003,1075020031,TwS,"BCG vaccine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1076,2003,1076020031,TwS,"Colchicine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1077,2003,1077020031,TwS,"Losartan with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1078,2003,1078020031,TwS,"cholecalciferol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1079,2003,1079020031,TwS,"Ibrutinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1080,2003,1080020031,TwS,"abiraterone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1081,2003,1081020031,TwS,"bicalutamide with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1082,2003,1082020031,TwS,"emtricitabine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1083,2003,1083020031,TwS,"tacrolimus with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1100,2003,1100020031,TwS,"antivirals in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1101,2003,1101020031,TwS,"immune-based therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1102,2003,1102020031,TwS,"antithrombotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1103,2003,1103020031,TwS,"antibiotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1104,2003,1104020031,TwS,"concomitant cardiovascular prevention therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1105,2003,1105020031,TwS,"antidiabetics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1106,2003,1106020031,TwS,"concomitant therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1001,2004,1001020041,TwS,"Hydroxychloroquine  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1002,2004,1002020041,TwS,"Hydroxychloroquine + Azithromycin  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1003,2004,1003020041,TwS,"Hydroxychloroquine + Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1004,2004,1004020041,TwS,"Hydroxychloroquine + Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1005,2004,1005020041,TwS,"Hydroxychloroquine + ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1006,2004,1006020041,TwS,"Chloroquine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1007,2004,1007020041,TwS,"Azithromycin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1008,2004,1008020041,TwS,"Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1009,2004,1009020041,TwS,"Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1010,2004,1010020041,TwS,"Ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1011,2004,1011020041,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1012,2004,1012020041,TwS,"tocilizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1013,2004,1013020041,TwS,"siltuximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1014,2004,1014020041,TwS,"sarilumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1015,2004,1015020041,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1016,2004,1016020041,TwS,"baricitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1017,2004,1017020041,TwS,"tofacitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1018,2004,1018020041,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1019,2004,1019020041,TwS,"adalimumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1020,2004,1020020041,TwS,"etanercept with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1021,2004,1021020041,TwS,"infliximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1022,2004,1022020041,TwS,"ustekinumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1023,2004,1023020041,TwS,"Anakinra with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1024,2004,1024020041,TwS,"HIV Protease inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1025,2004,1025020041,TwS,"ritonavir/lopinavir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1026,2004,1026020041,TwS,"Interferon beta 1b with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1027,2004,1027020041,TwS,"Interferon beta 1a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1028,2004,1028020041,TwS,"Interferon alfa 2a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1029,2004,1029020041,TwS,"favipiravir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1030,2004,1030020041,TwS,"Remdesivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1031,2004,1031020041,TwS,"ribavirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1032,2004,1032020041,TwS,"oseltamivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1033,2004,1033020041,TwS,"Ivermectin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1034,2004,1034020041,TwS,"itraconazole with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1035,2004,1035020041,TwS,"warfarin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1036,2004,1036020041,TwS,"heparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1037,2004,1037020041,TwS,"enoxaparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1038,2004,1038020041,TwS,"edoxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1039,2004,1039020041,TwS,"dabigatran with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1040,2004,1040020041,TwS,"rivaroxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1041,2004,1041020041,TwS,"acenocoumarol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1042,2004,1042020041,TwS,"apixaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1043,2004,1043020041,TwS,"bemiparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1044,2004,1044020041,TwS,"clopidogrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1045,2004,1045020041,TwS,"aspirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1046,2004,1046020041,TwS,"prasugrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1047,2004,1047020041,TwS,"alteplase with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1048,2004,1048020041,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1049,2004,1049020041,TwS,"tranexamic acid with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1050,2004,1050020041,TwS,"Ruxolitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1052,2004,1052020041,TwS,"ACE inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1053,2004,1053020041,TwS,"Angiotensin receptor blockers (ARBs) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1054,2004,1054020041,TwS,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1055,2004,1055020041,TwS,"Thiazide or thiazide-like diuretics with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1056,2004,1056020041,TwS,"Hydrocortisone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1057,2004,1057020041,TwS,"dexamethasone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1058,2004,1058020041,TwS,"prednisone or prednisolone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1059,2004,1059020041,TwS,"raloxifene with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1060,2004,1060020041,TwS,"Bevacizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1061,2004,1061020041,TwS,"Fingolimod with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1062,2004,1062020041,TwS,"eculizumab  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1063,2004,1063020041,TwS,"Statins with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1064,2004,1064020041,TwS,"metformin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1065,2004,1065020041,TwS,"DPP-4 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1066,2004,1066020041,TwS,"SGLT2 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1067,2004,1067020041,TwS,"GLP1 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1068,2004,1068020041,TwS,"H2 receptor antagonist with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1069,2004,1069020041,TwS,"famotidine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1070,2004,1070020041,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1071,2004,1071020041,TwS,"prazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1072,2004,1072020041,TwS,"terazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1073,2004,1073020041,TwS,"doxazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1074,2004,1074020041,TwS,"tamsulosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1075,2004,1075020041,TwS,"BCG vaccine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1076,2004,1076020041,TwS,"Colchicine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1077,2004,1077020041,TwS,"Losartan with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1078,2004,1078020041,TwS,"cholecalciferol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1079,2004,1079020041,TwS,"Ibrutinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1080,2004,1080020041,TwS,"abiraterone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1081,2004,1081020041,TwS,"bicalutamide with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1082,2004,1082020041,TwS,"emtricitabine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1083,2004,1083020041,TwS,"tacrolimus with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1100,2004,1100020041,TwS,"antivirals in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1101,2004,1101020041,TwS,"immune-based therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1102,2004,1102020041,TwS,"antithrombotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1103,2004,1103020041,TwS,"antibiotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1104,2004,1104020041,TwS,"concomitant cardiovascular prevention therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1105,2004,1105020041,TwS,"antidiabetics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1106,2004,1106020041,TwS,"concomitant therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1001,2005,1001020051,TwS,Hydroxychloroquine  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1002,2005,1002020051,TwS,Hydroxychloroquine + Azithromycin  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1003,2005,1003020051,TwS,Hydroxychloroquine + Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1004,2005,1004020051,TwS,Hydroxychloroquine + Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1005,2005,1005020051,TwS,Hydroxychloroquine + ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1006,2005,1006020051,TwS,Chloroquine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1007,2005,1007020051,TwS,Azithromycin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1008,2005,1008020051,TwS,Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1009,2005,1009020051,TwS,Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1010,2005,1010020051,TwS,Ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1011,2005,1011020051,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1012,2005,1012020051,TwS,tocilizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1013,2005,1013020051,TwS,siltuximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1014,2005,1014020051,TwS,sarilumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1015,2005,1015020051,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1016,2005,1016020051,TwS,baricitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1017,2005,1017020051,TwS,tofacitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1018,2005,1018020051,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1019,2005,1019020051,TwS,adalimumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1020,2005,1020020051,TwS,etanercept with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1021,2005,1021020051,TwS,infliximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1022,2005,1022020051,TwS,ustekinumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1023,2005,1023020051,TwS,Anakinra with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1024,2005,1024020051,TwS,HIV Protease inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1025,2005,1025020051,TwS,ritonavir/lopinavir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1026,2005,1026020051,TwS,Interferon beta 1b with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1027,2005,1027020051,TwS,Interferon beta 1a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1028,2005,1028020051,TwS,Interferon alfa 2a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1029,2005,1029020051,TwS,favipiravir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1030,2005,1030020051,TwS,Remdesivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1031,2005,1031020051,TwS,ribavirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1032,2005,1032020051,TwS,oseltamivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1033,2005,1033020051,TwS,Ivermectin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1034,2005,1034020051,TwS,itraconazole with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1035,2005,1035020051,TwS,warfarin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1036,2005,1036020051,TwS,heparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1037,2005,1037020051,TwS,enoxaparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1038,2005,1038020051,TwS,edoxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1039,2005,1039020051,TwS,dabigatran with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1040,2005,1040020051,TwS,rivaroxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1041,2005,1041020051,TwS,acenocoumarol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1042,2005,1042020051,TwS,apixaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1043,2005,1043020051,TwS,bemiparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1044,2005,1044020051,TwS,clopidogrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1045,2005,1045020051,TwS,aspirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1046,2005,1046020051,TwS,prasugrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1047,2005,1047020051,TwS,alteplase with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1048,2005,1048020051,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1049,2005,1049020051,TwS,tranexamic acid with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1050,2005,1050020051,TwS,Ruxolitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1052,2005,1052020051,TwS,ACE inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1053,2005,1053020051,TwS,Angiotensin receptor blockers (ARBs) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1054,2005,1054020051,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1055,2005,1055020051,TwS,Thiazide or thiazide-like diuretics with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1056,2005,1056020051,TwS,Hydrocortisone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1057,2005,1057020051,TwS,dexamethasone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1058,2005,1058020051,TwS,prednisone or prednisolone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1059,2005,1059020051,TwS,raloxifene with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1060,2005,1060020051,TwS,Bevacizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1061,2005,1061020051,TwS,Fingolimod with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1062,2005,1062020051,TwS,eculizumab  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1063,2005,1063020051,TwS,Statins with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1064,2005,1064020051,TwS,metformin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1065,2005,1065020051,TwS,DPP-4 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1066,2005,1066020051,TwS,SGLT2 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1067,2005,1067020051,TwS,GLP1 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1068,2005,1068020051,TwS,H2 receptor antagonist with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1069,2005,1069020051,TwS,famotidine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1070,2005,1070020051,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1071,2005,1071020051,TwS,prazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1072,2005,1072020051,TwS,terazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1073,2005,1073020051,TwS,doxazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1074,2005,1074020051,TwS,tamsulosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1075,2005,1075020051,TwS,BCG vaccine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1076,2005,1076020051,TwS,Colchicine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1077,2005,1077020051,TwS,Losartan with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1078,2005,1078020051,TwS,cholecalciferol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1079,2005,1079020051,TwS,Ibrutinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1080,2005,1080020051,TwS,abiraterone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1081,2005,1081020051,TwS,bicalutamide with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1082,2005,1082020051,TwS,emtricitabine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1083,2005,1083020051,TwS,tacrolimus with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1100,2005,1100020051,TwS,antivirals in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1101,2005,1101020051,TwS,immune-based therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1102,2005,1102020051,TwS,antithrombotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1103,2005,1103020051,TwS,antibiotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1104,2005,1104020051,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1105,2005,1105020051,TwS,antidiabetics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1106,2005,1106020051,TwS,concomitant therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1001,2006,1001020061,TwS,Hydroxychloroquine  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1002,2006,1002020061,TwS,Hydroxychloroquine + Azithromycin  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1003,2006,1003020061,TwS,Hydroxychloroquine + Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1004,2006,1004020061,TwS,Hydroxychloroquine + Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1005,2006,1005020061,TwS,Hydroxychloroquine + ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1006,2006,1006020061,TwS,Chloroquine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1007,2006,1007020061,TwS,Azithromycin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1008,2006,1008020061,TwS,Fluoroquinolones with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1009,2006,1009020061,TwS,Amoxicillin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1010,2006,1010020061,TwS,Ceftriaxone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1011,2006,1011020061,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1012,2006,1012020061,TwS,tocilizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1013,2006,1013020061,TwS,siltuximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1014,2006,1014020061,TwS,sarilumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1015,2006,1015020061,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1016,2006,1016020061,TwS,baricitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1017,2006,1017020061,TwS,tofacitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1018,2006,1018020061,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1019,2006,1019020061,TwS,adalimumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1020,2006,1020020061,TwS,etanercept with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1021,2006,1021020061,TwS,infliximab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1022,2006,1022020061,TwS,ustekinumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1023,2006,1023020061,TwS,Anakinra with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1024,2006,1024020061,TwS,HIV Protease inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1025,2006,1025020061,TwS,ritonavir/lopinavir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1026,2006,1026020061,TwS,Interferon beta 1b with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1027,2006,1027020061,TwS,Interferon beta 1a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1028,2006,1028020061,TwS,Interferon alfa 2a with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1029,2006,1029020061,TwS,favipiravir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1030,2006,1030020061,TwS,Remdesivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1031,2006,1031020061,TwS,ribavirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1032,2006,1032020061,TwS,oseltamivir with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1033,2006,1033020061,TwS,Ivermectin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1034,2006,1034020061,TwS,itraconazole with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1035,2006,1035020061,TwS,warfarin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1036,2006,1036020061,TwS,heparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1037,2006,1037020061,TwS,enoxaparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1038,2006,1038020061,TwS,edoxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1039,2006,1039020061,TwS,dabigatran with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1040,2006,1040020061,TwS,rivaroxaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1041,2006,1041020061,TwS,acenocoumarol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1042,2006,1042020061,TwS,apixaban with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1043,2006,1043020061,TwS,bemiparin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1044,2006,1044020061,TwS,clopidogrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1045,2006,1045020061,TwS,aspirin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1046,2006,1046020061,TwS,prasugrel with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1047,2006,1047020061,TwS,alteplase with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1048,2006,1048020061,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1049,2006,1049020061,TwS,tranexamic acid with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1050,2006,1050020061,TwS,Ruxolitinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1052,2006,1052020061,TwS,ACE inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1053,2006,1053020061,TwS,Angiotensin receptor blockers (ARBs) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1054,2006,1054020061,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1055,2006,1055020061,TwS,Thiazide or thiazide-like diuretics with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1056,2006,1056020061,TwS,Hydrocortisone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1057,2006,1057020061,TwS,dexamethasone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1058,2006,1058020061,TwS,prednisone or prednisolone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1059,2006,1059020061,TwS,raloxifene with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1060,2006,1060020061,TwS,Bevacizumab with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1061,2006,1061020061,TwS,Fingolimod with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1062,2006,1062020061,TwS,eculizumab  with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1063,2006,1063020061,TwS,Statins with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1064,2006,1064020061,TwS,metformin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1065,2006,1065020061,TwS,DPP-4 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1066,2006,1066020061,TwS,SGLT2 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1067,2006,1067020061,TwS,GLP1 inhibitors with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1068,2006,1068020061,TwS,H2 receptor antagonist with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1069,2006,1069020061,TwS,famotidine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1070,2006,1070020061,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1071,2006,1071020061,TwS,prazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1072,2006,1072020061,TwS,terazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1073,2006,1073020061,TwS,doxazosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1074,2006,1074020061,TwS,tamsulosin with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1075,2006,1075020061,TwS,BCG vaccine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1076,2006,1076020061,TwS,Colchicine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1077,2006,1077020061,TwS,Losartan with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1078,2006,1078020061,TwS,cholecalciferol with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1079,2006,1079020061,TwS,Ibrutinib with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1080,2006,1080020061,TwS,abiraterone with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1081,2006,1081020061,TwS,bicalutamide with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1082,2006,1082020061,TwS,emtricitabine with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1083,2006,1083020061,TwS,tacrolimus with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1100,2006,1100020061,TwS,antivirals in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1101,2006,1101020061,TwS,immune-based therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1102,2006,1102020061,TwS,antithrombotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1103,2006,1103020061,TwS,antibiotics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1104,2006,1104020061,TwS,concomitant cardiovascular prevention therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1105,2006,1105020061,TwS,antidiabetics in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1106,2006,1106020061,TwS,concomitant therapies in SCYLLA with Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
